Evidence map›Paper›PMID 29992525›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2018

In search of the vulnerable patient or the vulnerable plaque:

Jamie W Bellinge, Roslyn J Francis, Kamran Majeed, Gerald F Watts, Carl J Schultz

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. The effect of Vitamin-KJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Trial
  2. Review
  3. Artificial intelligence-based quantification of cardiac 18F-sodium fluoride uptake.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  4. Review
  5. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  6. Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  7. Aortic valve imaging usingEJNMMI physics · 2022
    Article
  8. Determinants ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  9. Iterative reconstruction incorporating background correction improves quantification of [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  10. Coronary artery calcification: More than meets the eye.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  11. Optimizing arterialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  12. Advances in Quantitative Analysis ofMolecular imaging · 2021
    Review
  13. Whole-vessel coronaryEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  14. Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  15. Analytical quantification of aortic valve 18F-sodium fluoride PET uptake.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jamie W BellingeDepartment of Cardiology, Royal Perth Hospital, 197 Wellington St, Perth, WA, 6000, Australia. Jamie.Bellinge@health.wa.gov.au.
Roslyn J FrancisSchool of Medicine, University of Western Australia, Perth, Australia.
Kamran MajeedDepartment of Cardiology, Royal Perth Hospital, 197 Wellington St, Perth, WA, 6000, Australia.
Gerald F WattsDepartment of Cardiology, Royal Perth Hospital, 197 Wellington St, Perth, WA, 6000, Australia.
Carl J SchultzDepartment of Cardiology, Royal Perth Hospital, 197 Wellington St, Perth, WA, 6000, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) remains a leading cause of death. Preventative therapies that reduce CVD are most effective when targeted to individuals at high risk. Current risk stratification tools have only modest prognostic capabilities, resulting in over-treatment of low-risk individuals and under-treatment of high-risk individuals. Improved methods of CVD risk stratification are required. Molecular imaging offers a novel approach to CVD risk stratification. In particular,

Indexed as

RadiopharmaceuticalsCardiovascular DiseasesCoronary Artery DiseaseFluorine RadioisotopesHumansPlaque, AtheroscleroticPositron-Emission TomographySodium FluorideVascular CalcificationFluorine-18Fluorine RadioisotopesRadiopharmaceuticalsSodium FluorideatherosclerosisCADdiagnostic and prognostic applicationimage analysismolecular imaging agentsPET

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.